The global high potency active pharmaceutical ingredients (APIs) market was valued at $14.4 billion in 2016 and is expected to grow at a CAGR of 10.3 percent over the forecast period, according to a report by Grand View Research Inc.
Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compounds. Increasing incidence of cancer resulted in increasing R&D pertaining to anticancer drugs which thereby propelling the demand for HPAPIs over the forecast period.
The rising number of biotech & pharmaceutical industry and increasing investments in R&D sector in developing economies such as Asia and Latin America regions are key factors expected to provide growth platform over the forecast period.
Rising incidence of cancer is expected to drive the HPAPI market over the forecast period. Side effects related to chemotherapy such as it also affects non-cancerous cells hence targeted therapy approach is gaining popularity as it does not harm non-cancerous cells. This is attributed to the rising demand of HPAPI in the future.
The characteristics possessed by these anticancerous drugs such as minimum exposure of drug to the non-cancerous cell & effectiveness are the factor contributing to the market growth. In addition, HPAPI is also used as antibody-drug conjugates (ADCs). ADC are the most important & effective treatment in combination with monoclonal antibodies & biologically active drug for the cancer.
The drug’s use for cancer treatment is cytotoxic in nature and is harmful to the non-cancerous cells which cause extensive damage to patient’s health. Pharmaceutical industry is facing challenge related to harmful side effects of these drugs on normal cells of the body. While the use of a less effective drug is ineffective in cancer treatment hence the need for targeted therapy approach came into existence. HPAPI target cancer tissue effectively coupled with minimum exposure of drugs to healthy tissues
HPAPI are most commonly used in hormonal drugs which are used in the treatment of breast cancer. Glaucoma is the other most important application of HPAPI. Increasing demand for drugs for the treatment of glaucoma is expected to drive the market growth. The HPAPIs also found application in cardiovascular drugs, central nervous system drugs and musculoskeletal drugs.
Increasing demand for these drugs during the forecast period is anticipated to propel the market growth in coming years. In addition, rising usage of HPAPI in gynaecology & cosmetics are accounted for the further growth
The global high potency active pharmaceutical ingredients (APIs) market was valued at $14.4 billion in 2016 and is expected to grow at a CAGR of 10.3 percent over the forecast period, according to a report by Grand View Research Inc.
Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compounds. Increasing incidence of cancer resulted in increasing R&D pertaining to anticancer drugs which thereby propelling the demand for HPAPIs over the forecast period.
The rising number of biotech & pharmaceutical industry and increasing investments in R&D sector in developing economies such as Asia and Latin America regions are key factors expected to provide growth platform over the forecast period.
Rising incidence of cancer is expected to drive the HPAPI market over the forecast period. Side effects related to chemotherapy such as it also affects non-cancerous cells hence targeted therapy approach is gaining popularity as it does not harm non-cancerous cells. This is attributed to the rising demand of HPAPI in the future.
The characteristics possessed by these anticancerous drugs such as minimum exposure of drug to the non-cancerous cell & effectiveness are the factor contributing to the market growth. In addition, HPAPI is also used as antibody-drug conjugates (ADCs). ADC are the most important & effective treatment in combination with monoclonal antibodies & biologically active drug for the cancer.
The drug’s use for cancer treatment is cytotoxic in nature and is harmful to the non-cancerous cells which cause extensive damage to patient’s health. Pharmaceutical industry is facing challenge related to harmful side effects of these drugs on normal cells of the body. While the use of a less effective drug is ineffective in cancer treatment hence the need for targeted therapy approach came into existence. HPAPI target cancer tissue effectively coupled with minimum exposure of drugs to healthy tissues
HPAPI are most commonly used in hormonal drugs which are used in the treatment of breast cancer. Glaucoma is the other most important application of HPAPI. Increasing demand for drugs for the treatment of glaucoma is expected to drive the market growth. The HPAPIs also found application in cardiovascular drugs, central nervous system drugs and musculoskeletal drugs.
Increasing demand for these drugs during the forecast period is anticipated to propel the market growth in coming years. In addition, rising usage of HPAPI in gynaecology & cosmetics are accounted for the further growth
No comments:
Post a Comment